Transactions
50 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|
| 2025-11-18 | Dunne Michael W. | - | Buy | 6,000 | $0.37 | $2,191.20 | +2.6% | → |
| 2025-08-08 | Dunne Michael W. | - | Buy | 15,000 | $0.72 | $10,854.00 | +6.8% | → |
| 2023-12-22 | Dunne Michael W. | Director | Buy | 25,000 | $1.40 | $35,000.00 | +28.2% | → |
| 2023-12-18 | Dunne Michael W. | Director | Buy | 10,000 | $1.84 | $18,442.00 | +12.7% | → |
| 2023-11-22 | Dunne Michael W. | Director | Buy | 20,000 | $2.03 | $40,690.00 | +34.0% | → |
| 2023-11-20 | Fishman Corey N. | Chief Executive Officer | Buy | 10,000 | $1.59 | $15,863.00 | +22.5% | → |
| 2022-12-02 | Puttagunta Sailaja | Chief Medical Officer | Sale+OE | 3,365 | $1.32 | $4,441.80 | -40.4% | → |
| 2022-09-20 | Ahrens Brenton Karl | Director | Sell | 37,246 | $1.82 | $67,930.20 | -55.8% | → |
| 2022-09-15 | Ahrens Brenton Karl | Director | Sell | 45,000 | $2.09 | $93,846.00 | -22.3% | → |
| 2022-09-12 | Ahrens Brenton Karl | Director | Sell | 33,298 | $2.31 | $76,802.52 | -10.2% | → |
| 2022-09-07 | Dunne Michael W. | Director | Buy | 10,000 | $2.22 | $22,200.00 | +39.1% | → |
| 2022-03-14 | Matthews Judith M. | Chief Financial Officer | Sale+OE | 47,132 | $0.38 | $17,910.16 | -36.6% | → |
| 2021-02-12 | DENNER ALEXANDER J | 10% Owner | Sell | 20,619,949 | $2.43 | $50,007,284.23 | -66.0% | → |
| 2021-01-26 | Fishman Corey N. | President & CEO | Sell | 85,445 | $1.73 | $147,819.85 | -21.0% | → |
| 2021-01-26 | Matthews Judith M. | Chief Financial Officer | Sell | 33,868 | $1.73 | $58,591.64 | -54.2% | → |
| 2021-01-26 | Dunne Michael W. | Director | Sell | 33,143 | $1.73 | $57,337.39 | -11.4% | → |
| 2020-10-27 | Dunne Michael W. | Chief Scientific Officer | Buy | 61,540 | $0.00 | - | +41.6% | → |
| 2020-09-30 | Matthews Judith M. | Chief Financial Officer | Sell | 56,130 | $1.64 | $92,053.20 | -100% | → |
| 2020-06-02 | Sofinnova Venture Partners IX, L.P. | - | Sell | 500,000 | $1.62 | $812,080.00 | -14.9% | → |
| 2018-11-30 | Kelly David George | Director | Buy | 10,000 | $6.29 | $62,887.00 | +104.7% | → |
| 2018-10-30 | Chin Mark | Director | Buy | 58,000 | $6.10 | $353,800.00 | +5.6% | → |
| 2018-09-04 | Dunne Michael W. | Chief Scientific Officer | Buy | 500 | $10.00 | $5,000.00 | +0.3% | → |
| 2018-08-27 | Dunne Michael W. | Chief Scientific Officer | Buy | 1,000 | $10.00 | $10,000.00 | +0.3% | → |
| 2018-08-23 | Edick Paul R | Director | Buy | 500 | $10.44 | $5,218.70 | +2.0% | → |
| 2018-08-17 | Fishman Corey N. | President & CEO | Buy | 2,000 | $8.73 | $17,465.60 | +0.8% | → |
| 2018-05-30 | Heron Patrick J | Director, 10% Owner | Buy | 456,099 | $13.00 | $5,929,287.00 | +42.1% | → |
| 2018-05-30 | CANAAN X L.P. | Director, 10% Owner | Buy | 506,656 | $13.00 | $6,586,528.00 | +41.3% | → |
| 2018-05-30 | Chin Mark | Director | Buy | 337,606 | $13.00 | $4,388,878.00 | +48.6% | → |
| 2018-05-30 | Lathi Vijay K | 10% Owner | Buy | 662,677 | $13.00 | $8,614,801.00 | +83.5% | → |
| 2018-05-30 | Sofinnova Venture Partners IX, L.P. | - | Buy | 500,000 | $13.00 | $6,500,000.00 | +40.8% | → |
| 2018-05-30 | HEALY JAMES | Director, 10% Owner | Buy | 500,000 | $13.00 | $6,500,000.00 | +40.8% | → |
| 2018-05-30 | Ahrens Brenton Karl | Director | Buy | 506,656 | $13.00 | $6,586,528.00 | +41.3% | → |
| 2018-05-30 | HUNT RONALD | Director, 10% Owner | Buy | 662,677 | $13.00 | $8,614,801.00 | +83.5% | → |
| 2018-05-30 | Malik Shahzad | Director | Buy | 236,984 | $13.00 | $3,080,792.00 | +37.5% | → |
| 2018-05-30 | Matthews Judith M. | Chief Financial Officer | Buy | 4,000 | $13.00 | $52,000.00 | +7.7% | → |
| 2018-05-30 | Dunne Michael W. | Chief Scientific Officer | Buy | 2,000 | $13.00 | $26,000.00 | +1.4% | → |
| 2018-05-30 | Fishman Corey N. | President & CEO | Buy | 3,000 | $13.00 | $39,000.00 | +1.3% | → |